Given that TGF-β1 is a crucial factor in the progression of liver fibrosis and has been reported to inhibit NDRG2 expression in HSCs, we validated the effects of NPLC0393 on TGF-β1-induced downregulation of NDRG2. Here, NDRG2 is linked to Hepatic fibrosis.